MedPath

Renetx Bio, Inc.

Renetx Bio, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2009-01-01
Employees
1
Market Cap
-
Website
http://www.renetx.com

AXER-204 in Participants With Chronic Spinal Cord Injury

Phase 1
Completed
Conditions
Chronic Spinal Cord Injury
Interventions
Drug: Placebo
First Posted Date
2019-06-18
Last Posted Date
2023-08-22
Lead Sponsor
ReNetX Bio, Inc.
Target Recruit Count
52
Registration Number
NCT03989440
Locations
🇺🇸

Spaulding Rehabilitation, Boston, Massachusetts, United States

🇺🇸

The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

🇺🇸

Shirley Ryan AbilityLab / Northwestern, Chicago, Illinois, United States

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath